A framework for efficient process development using optimal experimental designs by Ven, P.M. van de et al.
RESEARCH ARTICLE
A Framework for Efficient Process Development Using Optimal
Experimental Designs
Peter van de Ven & Sabina Bijlsma & Erik Gout &
Kees van der Voort Maarschalk & Uwe Thissen
Published online: 17 February 2011
# Springer Science+Business Media, LLC 2011
Abstract
Introduction The aim of this study was to develop and
demonstrate a framework assuring efficient process devel-
opment using fewer experiments than standard experimental
designs.
Methods A novel optimality criterion for experimental designs
(Iw criterion) is defined that leads to more efficient process
development because: (a) prior knowledge is used in the
experimental design to focus on optimal processing conditions
and (b) a lean design is used which can dramatically reduce the
number of experiments compared to standard designs. In this
way, the criterion serves as a framework to connect a series of
screening and optimization designs.
Results The philosophy behind the Iw criterion is explained
including a detailed step-wise discussion how to apply it in
practice. Moreover, its advantages were shown in an
industrial process development case using a screening and
an optimization design that were not explicitly connected.
In this paper, a reduction of 21% of experiments could be
obtained compared to the traditional approach using
standard experimental designs and no framework.
Conclusions The Iw criterion is a valuable tool to increase
accuracy and to speed up research that contain sets of
experiments and where prior knowledge is already available
or will be derived using screening designs.
Keywords Design of experiments (DOE) . Optimal
design . I optimal . Quality by design . Process development
Introduction
The main objective of pharmaceutical process development is
to design a manufacturing process that consistently yields
products of good quality. Besides crucial, this is also a
challenging task, as manufacturing processes typically consist
of several unit operations in which a large number of (process
and input) variables affect the quality of the final product.
Because of its expenses in time and money, there is a
large pressure to perform process development as concise
as possible. However, proper process development is also
crucial to ensure high quality and cost-efficient manufac-
turing. One of the greatest challenges is to obtain
quantitative information about interactions between (pro-
cess and input) variables with reasonable effort. The
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importance of interactions between variable is clearly
defined by the FDA's definition of the design space: “The
multidimensional combination and interaction of input
variables (e.g. material attributes) and process parameters
that have been demonstrated to provide assurance of
quality. Working within the design space is not considered
as a change. Movement out of the design space is
considered to be a change and would normally initiate a
regulatory post approval change process. Design space is
proposed by the applicant and is subject to regulatory
assessment and approval” [1].
It is evident that always some number of experiments is
needed to design the process (i.e., determine the design space
by finding appropriate process settings). Furthermore, it is
widely recognized that standard experimental designs, such as
(fractional) factorial designs, orthogonal arrays, or Plackett-
Burman designs offer large benefits over change-one-
parameter-at-a-time experiments. For a clear overview of the
use of experimental designs in the pharmaceutical industry,
we refer to [2, 3]. Frequently, it is shown that experimental
designs bear the advantage of requiring less experiments and
providing more reliable results, specifically about interac-
tions. However, pharmaceutical process development will
benefit even more from well-constructed experimental
designs if standard experimental designs (e.g., from text-
books or software) are replaced by approaches where results
from one set of experiments are used to select the design of
experimentation in a next stage: a multi-stage sequential
design approach. The advantage of this approach using prior
knowledge is twofold: (a) the total study is more focused on
the latest insights of the most interesting parameter settings
and (b) a statistical optimality criterion can be used to ensure
the smallest possible number of experiments.
As an example, in the literature, Bayesian D-optimal
designs have recently been proposed as a means to reduce
the experimental effort in a pharmaceutical process develop-
ment by using existing (i.e., prior) information in combination
with an optimality criterion [4]. In these situations, optimal
design theory chooses the settings for the factors in an
experiment in such a way that the expected amount of
information in the experiment is maximized. For the regular
D-optimality criterion, maximum information is defined by
maximizing the determinant of the variance-covariance
matrix for the estimators of regression coefficients (and,
equivalently, the volume of the confidence ellipsoid for these
coefficients). Bayesian D-optimal designs are an extension to
the regular D-optimal designs where information can be
taken into account that is already available on the values of
the regression coefficients. This prior information is incor-
porated in the design criterion by specification of a prior
distribution for the parameters. The idea of using available
information in choosing the experimental strategy can be of
great benefit in the sequential experimental procedures used
in pharmaceutical process development. The Bayesian D-
criterion, however, focuses on an accurate estimation of the
unknown parameters instead of finding the design space,
which is the essential reason of performing the experiments.
Therefore, solely relying on the D-optimality criterion may
result in a larger focus on combinations of parameter settings
for which it is unlikely that the final product will meet all
requirements. This will lead again to performing more
experiments than strictly required.
In this paper, we present an alternative design criterion
which specifically takes into account the latest insights on
the best set of parameter settings: the weighted, multivariate
I-criterion (Iw). The major benefit is that it focuses on the
region for which it is expected that all requirements are
met. The criterion is based on the standard I-criterion and
minimizes a weighted average prediction variance over the
experimental region. This novel and weighted criterion
assures that the criterion gives more weight to design points
that correspond to settings of the input and process
parameters for which it is likely that a final product will
meet the requirements (referred to a “preliminary design
space” in this document with the likeliness judged on the
basis of previous experiments). Typically, the designs that
are optimal with respect to the weighted I-criterion cover
the whole experimental region, but a larger proportion of
the design points is located in and at the edges of the region
where acceptance of the final product is deemed most
likely. In contrast to the D-criterion, the I-criterion
minimizes the error of the predictions, which corresponds
to an increased reliability of the design space.
The goal of this paper is to explain the strategy of a multi-
stage sequential design strategy for process optimization
where a novel Iw criterion is used to assure optimal experi-
ments (i.e., a minimal number of experiments with a maximal
reliability). The benefits of this approach are illustrated by
comparing its experimental load in an industrial case study
which only used conventional designs that were not connected
in a framework. Because of the mathematical basis of this new
approach, its theoretical power and performance will not be
affected compared to the traditional design.
Materials and Methods
Criteria for Optimization
A typical design approach consists of two steps: first a
screening study is performed to identify the most important
parameters and variables (perhaps preceded by a desk
study), followed by a new designed more consecutive
optimization experiment. In contrast, the approach pro-
posed in this paper explicitly uses the results of the
screening study to tune the optimization design. As an
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optimization design, a so-called optimal design is used.
Optimal designs are experimental designs that are optimal
with respect to a certain criterion. This criterion measures
how well a design performs with respect to a predefined
goal, such as the ability to estimate some unknown model
parameters or the prediction of a response variable.
Optimality criteria make it possible to compare different
designs [5, 6].
The previously mentioned D-criterion is based on
maximizing the information matrix which corresponds to
minimizing the total variance of the estimators (i.e., the
model parameters). In this study, the focus lies on finding
the settings of process parameters that are optimal for the
product quality. This means that a design is needed that is
optimal with respect to the predicted values (model
outcome) and not to the model parameters. The optimality
criterion used in this study is based on the I-criterion which
minimizes the average prediction variance by minimizing
the mean squared prediction error. In this paper we propose
an extension of the I-criterion: a multivariate and weighted
version of the I-criterion.
Adapted I-Optimality Criterion
Consider a standard linear model that relates a (univariate)
quality parameter vector y of random observations to a
column vector β of unknown parameters: y ¼ Xb þ ",
where X is an n times p matrix containing the levels (p)
of process parameters (and their interactions possibly, n)
and ε is a vector of independent random errors with mean 0
and variance σ2. The prediction y(x) at a point x is: y(x)=x
est(β), with est(β)=(XTX)−1XTy: the least-squares estima-
tor for β based on the data. The prediction variance at x
(i.e., the variance of y(x)) equals: V(x)=σ2 x (XTX)−1 x.
T
The standard I-optimal designs choose X (i.e., the settings
of the experiments) to minimize the average prediction
variance over an experimental region (R) of interest, that is,
they minimize:
ð1Þ
where G(R) is a fine grid, covering the complete region of
R. If prior knowledge is available then low prediction
variance may be desired especially in a subregion of R (i.e.,
the subregion where meeting of acceptance criteria is
considered most likely). In such cases, (1) may be replaced
by
ð2Þ
where w(x) is a pre-specified weight-function with weights
that are different in the subregion compared to the rest of G(R).
The criterion in (2) may be referred to as the weighted I-
optimality criterion. In cases where multiple quality parame-
ters need to be considered (y1, y2, .., yN), this approach is also
valid if it is possible to use the same independent variables
and interactions for each response variable. It is important to
note that the weight-function is user-defined. This is also the
great advantage of this approach over standard, non-weighted,
criteria, The user can put more weight to design points that
correspond to settings of the input and process parameters that
(based on previous experiments) are more likely to result in a
final product meeting all requirements. Typically, the designs
that are optimal with respect to the weighted I-criterion (Iw)
cover the whole experimental region, but a relatively larger
proportion of the design points will be located in and around
the region where acceptance of the final product is deemed
most likely. The approach therefore supports the improve-
ments mentioned in the introduction: (a) using prior knowl-
edge the design is focused on the optimal region and (b) the
use of an optimality criterion ensures a lean design which can
dramatically reduce the number of experiments in a standard
design.
Application of the Adapted I-Optimality Criterion
in Process Design
In order to establish such an approach, the abovementioned
theoretical building blocks are combined into a practical
workflow which consists of eight steps (Fig. 1). The first
step is to collect historical and expert knowledge to define
and prioritize all process parameters, product quality
parameters, and their interactions (step 2). Based on this
information, in step 3 a screening experiment (usually 2-
level) is performed to establish the relations between the
highest priority process and product parameters. In step 4,
regression models are defined on basis of the screening
design. The purpose of these models is to predict the
combinations of parameters and settings that lead to the
desired product: the “preliminary design space”. Step 5
defines the range of the experimental region for the
optimization experiments, based on expert knowledge.
Ideally, this region (partly) overlaps the initial region which
means that the predictions in the next step are based on
interpolation rather than extrapolation. The region is
defined by a discrete grid where each point is a candidate
setting (see Eqs. 1 and 2). It is clear that the grid points
should reflect relevant and practically feasible settings. In
step 6, the prediction models are used to determine the
preliminary design space. This means that for all points in
the optimization region, the product quality parameters are
predicted. The preliminary design space consists of those
points for which the product quality parameters meet all
quality requirements. Step 7 consists of attributing weights
to the points inside and outside of the preliminary design
space. The weights within the design space are usually set
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to 1. The weights outside this space are defined relative to
the weights within the design space and express the
confidence in the preliminary design space. Unfortunately,
there is no objective criterion to define these weights. For
this reason, expert opinion or a rule of thumb is used to
define these weights. As a rule of thumb, we suggest to first
calculate the fraction (F) of the number of points inside the
preliminary control space. Second, the weights outside of
this region should be approximately F/(2−2F). This means
that average weight inside of the preliminary design space
(1×F) is about twice as high as the weight outside of this
region which again reflects the confidence of the user on
the preliminary design space. In the analysis of the case
study and the discussion, the aspect of weight selection is
discussed in more detail. In step 8, an exchange algorithm
(3) is used to find the Iw optimal design. First, a desired
number of design points is selected at random from a
candidate set to form a starting design for the algorithm. In
subsequent steps of the algorithm, exchanges of points in
the design and the candidate set are considered and the
exchange that results in the largest decrease of the Iw
criterion is selected at each step. This is repeated until none
of the possible exchanges yields a lower Iw criterion.
During this procedure, it is constantly assured that all the
candidate sets are able to assess all required effects by only
considering sets which rank is larger than zero. The
procedure is performed for several starting designs and
the design with smallest value for the Iw criterion is chosen
as the optimal design.
Software
The regression models have been calculated using SAS
9.1.3 (service pack 4, Copyright 2002–2003 by SAS
institute Inc., Cary, NC, USA) for windows. All other
calculates have been performed using home-made Matlab
7.7.0 software for windows (The Mathworks, MA, USA).
Results
In order to test the suggested approach, it was applied on a
real-world industrial application: the process development
of a tablet product. Before applying the proposed strategy
of this paper, the process development had already been
performed completely using standard experimental designs
in two consecutive stages. However, in contrast to this
study, no thorough framework had been used to connect
these stages. Based on the existing data of both stages 1 and
2, this section shows how to use the experiments of stage 1
to model a preliminary design space, how to use the Iw
criterion to define the suggested optimal design (stage 2)
and the comparison of the optimal design with the standard
design that was used in practice. It is important to note that
the Iw criterion was only used to define the optimization
design (stage 2) and not the stage 1 screening design
because these results are needed to define the Iw.. Because
of the mathematical background of this approach, the
number of experiments in the design and the optimality
criterion can be used as objective criteria to compare the
quality of the alternative and the original designs.
Example Case: Pharmaceutical Process Development
The manufacturing process of this tablet formulation
consists of six unit operations: granulation, drying and
Step    1. Collect expert and historical 
knowledge (e.g. brainstorm, data base, etc).
Step 2. Define set of factors with possible 
effect on product quality.
Step 3. Screening experiment: determine 
critical process parameters.
Step 4. Regression analysis: models to 
predict preliminary design space.
Step 5. Determine grid of process parameters 
for the optimization design. 
Step 6. Predict preliminary design space 
within the grid of new experiments.
Step 7. Define weights for the points on the 
grid of new experiments. 
Step 8. Determine optimal number of runs 
(Iw criterion) and compare with alternative, 
standard design. 
Fig. 1 Framework for an optimization strategy using multi-stage
designs (high flexibility) and the Iw optimality criterion (high
efficiency)
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milling, final mixing with lubricant, compression into
tablets, and film coating. Before constructing the Iw, as a
very first step in the process development, a brainstorm
meeting was performed with several in-house experts to
determine the list of 108 parameters and their estimated
influence on the 12 relevant product attributes. From this
inventory, the expert scores were summed leading to a
selection of ten allegedly important parameters that is
further investigated in a two-level screening design (i.e.,
investigating a “high” and a “low”-level) with respect to
two important product attributes: mean crushing strength
and mean disintegration time of tablets. The process
parameters are: amount of granulation water, addition time
of water during granulation, speed mixer, granulation time
(from the unit of granulation); loss on drying (from the unit
of drying); mixing speed blender, blending time (from the
unit of blending); tabletting speed, pre-compression force,
main compression force (from the unit operation of
compression). Based on the screening experiment three
process parameters were identified and the minimum and
maximum of the levels were defined. Two of these were
adjusted (amount of granulation time and addition time of
water) because it was observed that the preliminary design
space was at the edge of the investigated range while it is
better to have this region at the center of the investigated
range. Finally, a 32-run three-level full factorial experiment
was performed to find the optimal settings of the three
process parameters identified in the screening experiment.
The reader is referred to Table 1 for the levels of the
screening and the original follow-up design.
The alternative Iw-criterion based approach to connect
stages 1 and 2 and to determine the optimal stage 2
experiments was performed as follows. First, the results
from the screening design were used to find a quantitative
model for the two response parameters, mean crushing
strength (y1) and mean disintegration time (y2) based on the
three most important process parameters: amount of
granulation water (x1), addition time of granulation water
(x2) and granulation time (x3):
& y1 ¼ 1:57 0:29x1 þ 0:13x2  0:18x3 þ 0:19x1x2
þ0:06x2x3  0:02x1x3
& y2 ¼ 0:79 0:02x1  0:04x2  0:07x3  0:53x1x2
0:49x2x3 þ 0:56x1x3:
Next, a grid is defined that corresponds to the range of
product parameters that should be investigated in the
optimization experiments. For each point on the grid (i.e.,
for each possible setting of the product parameters in the
investigated range), the response parameters are predicted
using the abovementioned models. The combination of
grid points for which the predicted response parameters
meet the quality requirements is considered the prelimi-
nary design space. In this study, these requirements are
mean crushing strength >90 N and mean disintegration
time between 1 and 15 min. Note that it is important to
realize that if the range of the screening design and the
optimization designs are not equal, the prediction of the
response parameters relies on extrapolation of the derived
models. Although this situation is not desired for predic-
tion purposes, it is a valid approach to derive a first
estimate. Grid points in the preliminary design space (i.e.,
the predictions satisfy all requirements) receive a weight
equal to 1, whereas points with at least one constraint not
satisfied obtain a smaller weight. The weight given to the
points outside of the preliminary design space should
reflect the certainty of the results of earlier experiments.
Based on these settings, finding the optimal design is a
matter of automatically evaluating different combinations
of candidate design points, as is described in step 8 of
Fig. 1. Because a higher weight is given to points in the
preliminary design space, this space has a high positive
influence on the final experimental settings that are
selected. However, it is crucial that the points outside of
this region are also considered as candidates although with
a lower importance.
A special point of attention is the selection of the values
of the weights which can reflect the percentage of the
points in the grid that are in the preliminary design space.
In the case study, only a small fraction of 9.1% grid points
lie in the preliminary design space. This should be taken
into account when choosing the weights. For weights 0.1
(∼91% of the grid points) and 1.0 (∼9% of the grid points),
the average I-criterion approximately is the same inside and
outside of the preliminary design space. By choosing w=
0.05 we make the average prediction variance inside the
control space two times as important. Because there is no
Table 1 Levels for factors in screening (32 runs) and follow-up stage
(32 runs)
Levels
Screening
experiment
(stage 1)
Follow-up
experiment
(stage 2)
Granulation time (min) 4 4
6 5
6
Amount of granulation water (g) 6000 5500
7500 6250
7000
Addition time of water (s) 30 60
120 90
120
28 J Pharm Innov (2011) 6:24–31
objective criterion to set these weights, in this case, the
sensitivity of the total approach was investigated by using
different weights (0.025, 0.05, 0.1, 0.3, and 0.5) and
calculating their corresponding optimal designs (Table 2).
Table 2 shows that the lower the weight of the points
outside the preliminary design space, the less design points
are required to find a design with the same or better
characteristics than the full factorial design. This is because
more design points will stem from the preliminary design
space. It is also clear that with a weight of 0.1 (i.e., the
average weight outside and inside of the preliminary design
space is equal), this approach still finds a design with less
required experiments than the full factorial design (i.e., 27
instead of 32, a reduction of 15%). For the weights of 0.05
and 0.025, the reductions are 21% and 31%, respectively.
For hypothetical cases where the preliminary design space
is given less average importance than the other space, the
results converge to 32-run designs which are equal to the
full factorial design. This means that the concept of
optimality criteria will lead to no extension of the number
of experiments compared to standard designs: at the worst
the number of experiments is equal. Table 3 compares the
settings for the three process parameters for both the
optimal design (weight of 0.05) and the original design. It
is clearly seen that the new design contains practical levels
that can easily be set (e.g., integers or values with limited
decimals) and is comparably practical to the original
design. This is ensured by a proper definition of the grid
points. Finally, the improved quality of this approach has
become clear from the lower number of experiments, lower
Iw-criterion and the framework with a higher focus on the
preliminary design space.
Discussions
In the presented strategy, there are two main aspects
that need special attention. The first one relates to the goal
of process development: finding optimal settings or
the design space, while the second one relates to the
methodology presented in this paper: determining the
weights.
Irrespective of the approach followed (using the Iw
criterion or using standard sequential designs without a
systematic framework), the key assumption is that the
screening design and the correspondingly derived prelim-
inary design space are a good prediction of the final
design space. This is not necessarily the case, even though
these are the best available estimates. This risk becomes
smaller if the available knowledge and level of expertise is
higher which in its turn should lead to a better screening
design (i.e., containing the proper factors and levels). In
addition, a more efficient design approach, as shown in
this study, also opens the opportunity to use the same
number of experiments compared to standard approaches.
The excess of experiments can be used to focus on areas
where prior knowledge or expert opinion is less mature,
lowering the unavoidable subjective part of process
development. Moreover, the advantage of the Iw criterion
is that there is an explicit focus for the optimization design
on the region outside of the preliminary design space. In
the case where the preliminary design space is shifted
from the true (but partly unknown) one, it is likely that the
latter is still included in the optimization design. An
alternative approach might be to not only set higher
weights (e.g., 1) to the grid points in the preliminary
design space but also higher weights (e.g., 2) to the grid
points 20% around the borders of the preliminary design
space. The points outside both of these regions are given a
lower weight (e.g., 0.05).
The second point of attention corresponds to selecting
the values of the weights. Essentially, this comes down to
the level of confidence the researchers have with respect to
the existing knowledge, the screening design, and the
preliminary design space. This is not different from the
standard approach although it can be difficult to translate a
subjective feeling into a numeric value. For this reason we
have suggested a rule of thumb which ensures equal
average weight values inside and outside of the preliminary
design space. Moreover, this paper also shows what
happens if different values are selected: the results can
vary considerably. It might be a good approach to calculate
different options (using different set of weights) and
Table 2 The Iw values for different weights and different number of
experiments in the experimental design
w=0.025 w=0.05 w=0.1 w=0.3 w=0.5
FFD (N=32) 0.0247 0.0281 0.0384 0.0723 0.1063
N=20 0.0271 0.0358
N=21 0.0257 0.0340
N=22 0.0243 0.0320
N=23 0.0233 0.0303
N=24 0.0289 0.0430
N=25 0.0279 0.0414
N=26 0.0267 0.0399
N=27 0.0256 0.0380
N=28 0.0248 0.0369 0.0772 0.1160
N=32 0.0320 0.0669 0.1004
The Full Factorial Design (FFD) is considered as a reference (bold)
The Iw value that is smaller than the reference with the least number
of experiments is underlined
The blank cells represent trivial results which do not contribute to this
study
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visually compare the results to a standard optimization
design. From this the researcher can learn what design (i.e.,
weight) corresponds to the available but subjective level of
confidence.
Conclusions
This paper presents a framework in which experiments can
be designed for process development. Unlike standard
approaches, prior knowledge (from historical processing
data, expert knowledge, or a screening design) is explicitly
used to set up an optimization design, focused on process
parameter settings which are most likely to be highly
important. With this approach it becomes possible to
construct dedicated experimental designs that perform
equally or better than standard designs but require fewer
experiments. A crucial aspect in this framework is the novel
Iw optimality criterion for finding optimal designs while
taking into account parameter sub-regions which seem to be
more important without neglecting other regions to avoid
missing important information.
Table 3 The settings of the three process parameters for both the Iw-based optimal design and the original full factorial design with replicated
center points
Run number Optimal design Original design
Amount of
granulation water (g)
Addition time
of water (s)
Granulation
time (min)
Amount of
granulation water (g)
Addition time
of water (s)
Granulation
time (min)
1 5675 78 5 5500 120 6
2 5000 78 4.8 6250 90 5
3 6500 102 5 6250 90 5
4 5750 96 5 6250 60 5
5 5000 99 4 6250 60 6
6 5600 99 4 5500 60 6
7 5600 120 4 5500 60 5
8 5000 120 4 5500 60 4
9 5750 99 5 7000 60 5
10 5000 99 4.8 7000 90 4
11 5750 96 5 6250 120 6
12 5600 99 4 6250 90 5
13 6500 78 6 5500 90 4
14 5675 78 4 7000 120 5
15 6500 120 4 7000 60 4
16 5000 99 4 6250 90 5
17 5600 120 6 6250 120 4
18 6500 120 6 5500 90 5
19 5000 102 6 6250 120 5
20 5000 78 6 7000 60 6
21 5000 120 5 6250 90 5
22 5000 78 4 6250 60 4
23 5000 78 4 5500 90 6
24 6500 78 4 6250 90 5
25 5000 102 4.8 6250 90 6
26 7000 90 5
27 7000 120 4
28 5500 120 5
29 5500 120 4
30 6250 90 4
31 7000 90 6
32 7000 120 6
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The developed strategy was applied on a pharmaceutical
case study from which both a screening and an optimization
design have been developed in a traditional manner. In
contrast, this study shows from a theoretical perspective
that a reduction of 21% (seven experiments) is possible
while the theoretical power or the performance of the
approach was not affected compared to the traditional
design. In general, the reduction of experiments depends on
the problem at hand but in the worst case, the proposed Iw
strategy will converge to the standard design. Moreover, the
development of such a tailor-made optimization strategy
will not take more resources than the traditional approach
because the calculations are performed automatically. This
also allows the use of this approach in parallel to a standard
approach, as an objective critical reviewer.
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